Index of artpub/2017/289300/

Cabrero, Monica
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma : A GELTAMO Trial
2017
https://ddd.uab.cat/record/289300
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Cabrero,_Monica2024-10-01 16:17 16  
[ ]2=Phase_II_Study_of_Yttrium-90-Ibritumomab...2024-10-01 16:17 236  
[ ]3=20172024-10-01 16:17 5  
[ ]4=2893002024-10-01 16:17 34  
[TXT]289300.dirinfo2025-02-07 02:57 317  
[ ]289300.du2025-02-07 02:57 26  
[TXT]289300.dupdirs2025-02-07 02:57 0  
[TXT]289300.dupfiles2025-02-07 02:57 0  
[TXT]289300.errors2025-02-07 02:57 29  
[IMG]289300.gif2025-02-07 02:57 22K 
[IMG]289300.ico2025-02-07 02:57 12K 
[TXT]289300.info2025-02-07 02:57 26K 
[TXT]289300.md52025-02-07 02:57 45  
[ ]289300.pdf2025-02-07 02:57 784K 
[TXT]289300.sha12025-02-07 02:57 53  
[TXT]289300.sha2562025-02-07 02:57 77  
[TXT]289300.stats2025-02-07 02:57 265  
[TXT]289300.txt2025-02-07 02:57 0